HepQuant, LLC
HepQuant’s unique technology provides accurate, safe, and cost-effective liver function testing to enable chronic liver disease research and drug development.
- Stage Prototype Ready
- Industry Biotechnology
- Location Greenwood Village, CO, US
- Currency USD
- Founded June 2007
- Employees 0
- Website hepquant.com
Company Summary
HepQuant is an early-stage medical diagnostics company with unique, patented and patent-pending noninvasive liver tests: HepQuant-SHUNT, -FLOW, and -STAT. Revenue is based on contracts for test performance and lab analysis. In Phase 1 of our business plan, we will focus on expanding accounts with pharma partners and liver research centers. In Phase 2, we will directly market tests to care providers, insurers, and third-party payors.
Team
-
Gregory T. Everson, MD, FACPFounder, Chief Medical Officer
-
Randall Dietrich, MBA, CPAInterim CEO, Managing Member
-
Steve Helmke, Ph. DConsulting Technical Manager, Laboratory Affairs
-
Jennifer PayneConsulting Financial Manager
-
Lisa Goggin, MBA, CPCUManaging Director of Business Operations
-
Tom Kennedy, MBAManaging Director, Investor Relations & Marketing
-
Bradley EversonManaging Director, Sales & Business Development
Advisors
-
Daniel Wobbekind, Cooley, LLLPLawyerUnconfirmedCurrently unaudited.AccountantUnconfirmed
Previous Investors
-
Confidential. Available Upon RequestUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.